tirzepatide bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial Obesity drug seen as effective

Results: Incidental SLD was overall associated with cardiovascular diseases: HR (CI) was 1.33 (1.15-1.54) for myocardial infarction, 1.24 (1.14-1.36) for coronary artery disease (CAD), 1.26 (1.12-1.46) for heart failure, and 1.17 (1.04-1.31) for stroke

10.1111/j.1463-1326.2010.01251.x 44 LuW.WangS.TangH.YuanT.ZuoW.LiuY

Compounded semaglutide from U.S

Fatigue and jet lag Semaglutide can cause fatigue in some users, especially during dose increases

Traversi et al., 2016), which provides greater oral bioavailability, half-life, lipophilicity and higher permeability to targeted tissue (Kapetanovic et al., 2011

I dont believe GLP-1s are the only answerbut they are one option